Ultrasound triggered cell death in vitro with doxorubicin loaded poly lactic-acid contrast agents

Ultrasonics

Volumn 49, Issue 8, 2009, Pages 628-633

  Eisenbrey, J R ^a   Huang, P ^a   Hsu, J ^a   Wheatley, M A ^a  

^a DREXEL UNIVERSITY   (United States)

Author keywords

Doxorubicin; Drug delivery; Poly lactic acid; Ultrasound contrast agents

Indexed keywords

AREA OF INTEREST; BREAST CANCER CELLS; CANCER THERAPY; CELLULAR UPTAKE; CONTRAST AGENT; DOXORUBICIN; HEALTHY TISSUES; IN-CELL; IN-VITRO; INSONATION; POLY LACTIC-ACID; POLYMER SHELL; POSITIVE PRESSURE; PRESSURE AMPLITUDES; PULSE REPETITION FREQUENCIES; SHELL SURFACE; SURFACE ADSORPTION; ULTRASOUND CONTRAST AGENT; ULTRASOUND CONTRAST AGENTS;

ACIDS; ACOUSTIC WAVES; ADSORPTION; CELL DEATH; CELL MEMBRANES; CHEMOTHERAPY; DRUG DELIVERY; SHELLS (STRUCTURES); TOXICITY; ULTRASONICS;

ULTRASONIC IMAGING;

ANTINEOPLASTIC ANTIBIOTIC; CONTRAST MEDIUM; DOXORUBICIN; LACTIC ACID; POLYLACTIC ACID; POLYMER;

APOPTOSIS; ARTICLE; BREAST TUMOR; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG EFFECT; ELECTROPORATION; HUMAN; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; RADIATION DOSE; RADIATION EXPOSURE; RADIATION RESPONSE; TUMOR CELL LINE; ULTRASOUND;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CONTRAST MEDIA; DELAYED-ACTION PREPARATIONS; DOSE-RESPONSE RELATIONSHIP, RADIATION; DOXORUBICIN; ELECTROPORATION; HUMANS; LACTIC ACID; POLYMERS; RADIATION DOSAGE; SONICATION;

EID: 70350582843     PISSN: 0041624X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ultras.2009.03.003     Document Type: Article

References (24)

1. Jain R.K. Delivery of molecular medicine to solid tumors. Science 271 (1996) 1079-1080
2. Jain R.K. Barriers to drug delivery in solid tumors. Scientific American 271 (1994) 58-65
3. Singal P., and Ilskovic N. Doxorubicin-induced cardiomyopathy. New England Journal of Medicine 339 (1998) 900-905
4. Goldberg B.B., Raichlen J.S., and Forsberg F. Ultrasound Contrast Agents: Basic Principles and Clinical Applications. second ed. (2001), Martin Dunitz, London
5. Wheatley M.A., Forsberg F., Oum K., et al. Comparison of in vitro and in vivo acoustic response of a novel 50:40 PLGA contrast agent. Ultrasonics 44 (2006) 360-367
6. Straub J.A., Chickering D.E., Church C.C., et al. Porous PLGA microparticles: AI-700, an intravenously administered ultrasound contrast agent for use in echocardiography. Journal of Controlled Release 108 (2005) 21-32
7. Mitragotri S. Healing sound: the use of ultrasound in drug delivery and other therapeutic applications. Nature Reviews 4 (2005) 255-260
8. Dijkmans P.A., Juffermans L.J., Musters R.J., et al. Microbubbles and ultrasound: from diagnosis to therapy. European Journal of Echocardiography 5 (2004) 245-256
9. Unger E.C., McCreery T.P., Sweitzer R.H., et al. Acousticaly active lipospheres containing paclitaxel: a new therapeutic ultrasound contrast agent. Investigative Radiology 33 (1998) 886-892
10. Kooiman K., Böhmer M.R., Emmer M., et al. Oil-filled polymer microcapsules for ultrasound - mediated delivery of lipophillic drugs. Journal of Controlled Release 133 (2008) 109-118
11. Shi W.T., van Wamel A., Celebi M., et al. Ultrasound therapy with drug loaded microcapsules. IEEE Ultrasonics Symposium (2007) 773-776
12. El-Sherif D., and Wheatley M.A. Development of a novel method for the synthesis of a polymer ultrasound contrast agent. Journal of Biomedical Materials Research 66A (2003) 347-357
13. Narayan P., and Wheatley M.A. Preparation and characterization of hollow microcapsules for use as ultrasound contrast agents. Polymer Engineering and Science 39 (1999) 2242-2255
14. Eisenbrey J.R., Huang P., Soulen M.C., et al. Doxorubicin loaded contrast agents for ultrasound triggered drug delivery: importance of process parameters. Pharmaceutical Engineering 28 (2008) 70-78
15. Ohl C., Arora M., Ikink R., et al. Sonoporation from jetting cavitation bubbles. Biophysical Journal 91 (2006) 4285-4295
16. Prentice P., Cuschieri A., Dholakia K., et al. Membrane disruption by optically controlled microbubble cavitation. Nature Physics 1 (2005) 107-110
17. Wu J., and Nyborg L. Ultrasound, cavitation bubbles and their interaction with cells. Advanced Drug Delivery Reviews 20 (2008) 1103-1116
18. Tran T.A., Roger S., Le J.Y., et al. Effects of ultrasound activated microbubbles on the cell electrophysiological properties. Ultrasound in Medicine and Biology 33 (2006) 158-163
19. van Wamel A., Kooiman K., Harteveld M., et al. Vibrating microbubbles poking individual cells: drug transfer into cells via sonoporation. Journal of Controlled Release 112 (2006) 149-155
20. Kinoshita M., and Hynynen K. Intracellular delivery of Bak BH3 peptide by microbubble-enhanced ultrasound. Pharmaceutical Research 22 (2005) 716-720
21. Miao C.H., Brayum A.A., Loeb K.R., et al. Ultrasound enhances gene delivery of human factor IX plasmid. Human Gene Therapy 16 (2005) 893-905
22. Bekeredjian R., Katus H.A., and Kuecherer H.F. Therapeutic use of ultrasound targeted microbubble destruction: a review of non-cardiac applications. Ultraschall in der Medizin 27 (2006) 134-140
23. Bloch S.H., Wan M., Dayton P.A., et al. Optical observation of lipid- and polymer-shelled ultrasound microbubble contrast agents. Applied Physics Letters 84 (2004) 631-633
24. Chen W., Matula T.J., Brayman A.A., et al. A comparison of the fragmentation thresholds and inertial cavitation doses of different ultrasound contrast agents. Journal of the Acoustical Society of America 113 (2002) 641-651